Aliases & Classifications for Bronchitis

MalaCards integrated aliases for Bronchitis:

Name: Bronchitis 12 3 42 14 69
Chronic Bronchitis 12 29 41
Acute Bronchitis 12 41 69
Bronchitis, Chronic 42 69
Chest Cold 12 3
Acute Lower Respiratory Tract Infection 69
Acute Bronchitis and Bronchiolitis 12
Lower Respiratory Tract Infection 69
Recurrent Wheezy Bronchitis 12
Ci - Chest Infection 12
Bronchitis Chronic 52
Chest Infection 12

Classifications:



Summaries for Bronchitis

MedlinePlus : 41 bronchitis is an inflammation of the bronchial tubes, the airways that carry air to your lungs. it causes a cough that often brings up mucus. it can also cause shortness of breath, wheezing, a low fever, and chest tightness. there are two main types of bronchitis: acute and chronic. most cases of acute bronchitis get better within several days. but your cough can last for several weeks after the infection is gone. the same viruses that cause colds and the flu often cause acute bronchitis. these viruses spread through the air when people cough, or though physical contact (for example, on unwashed hands). being exposed to tobacco smoke, air pollution, dusts, vapors, and fumes can also cause acute bronchitis. less often, bacteria can also cause acute bronchitis. to diagnose acute bronchitis, your health care provider will ask about your symptoms and listen to your breathing. you may also have other tests. treatments include rest, fluids, and aspirin (for adults) or acetaminophen to treat fever. a humidifier or steam can also help. you may need inhaled medicine to open your airways if you are wheezing. antibiotics won't help if the cause is viral. you may get antibiotics if the cause is bacterial. nih: national heart, lung, and blood institute

MalaCards based summary : Bronchitis, also known as chronic bronchitis, is related to balkan nephropathy and pyelonephritis, and has symptoms including coughing, fever and pruritus. An important gene associated with Bronchitis is ELANE (Elastase, Neutrophil Expressed), and among its related pathways/superpathways are Innate Immune System and Allograft rejection. The drugs Augmentin and Avelox I.V. have been mentioned in the context of this disorder. Affiliated tissues include lung, testes and skin, and related phenotypes are hematopoietic system and immune system

Disease Ontology : 12 A bronchial disease that is an inflammation of the bronchial tubes. It is caused by bacteria and viruses. The disease has symptom cough with mucus, has symptom shortness of breath, has symptom low fever and has symptom chest tightness.

CDC : 3 Since their discovery in the 1920s, antibiotics have transformed our ability to treat infections. As antibiotic resistance increases, these lifesaving drugs do not work as well as they once did, and successfully treating common infections becomes more difficult.

Wikipedia : 72 Bronchitis is inflammation of the bronchi (large and medium-sized airways) in the lungs. Symptoms... more...

Related Diseases for Bronchitis

Diseases related to Bronchitis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 357)
id Related Disease Score Top Affiliating Genes
1 balkan nephropathy 30.3 ALB IL5 RNASE3
2 pyelonephritis 30.0 CFTR CXCL8 TNF
3 lung disease 29.8 CD40LG TNF
4 pulmonary embolism 29.3 ALB CD40LG CXCL8 TNF
5 transient hypogammaglobulinemia 29.0 CD40LG CD79A
6 lymphoma 28.0 ALB CD40LG CD79A IL5 TNF
7 asthma 26.8 CCL11 CD40LG CD79A CFTR CXCL8 ELANE
8 acute chest syndrome 24.9 ALB CCL11 CD40LG CD79A CFTR CXCL8
9 plastic bronchitis 12.3
10 cystic fibrosis 11.1
11 pulmonary disease, chronic obstructive 11.1
12 lung cancer 11.0
13 bronchial disease 11.0
14 autoimmune oophoritis 10.9 MPO TNF
15 papillary follicular thyroid adenocarcinoma 10.8 IL5 RNASE3
16 common peroneal nerve lesion 10.8 CXCL8 IL5
17 penis agenesis 10.8 CCL11 IL5
18 whistling face syndrome, recessive form 10.7 CXCL8 IL5 RNASE3
19 congenital dyserythropoietic anemia 10.7 ALB TNF
20 burns 10.7 CXCL8 ELANE RNASE3
21 placenta praevia 10.7 ALB ELANE MPO
22 agammaglobulinemia, x-linked 1 10.7
23 ciliary dyskinesia, primary, 7, with or without situs inversus 10.7
24 severe combined immunodeficiency 10.7
25 chronic laryngitis 10.7
26 actinobacillosis 10.7
27 agammaglobulinemia, non-bruton type 10.7
28 parainfluenza virus type 3 10.7
29 cannabis abuse 10.7 CCL11 IL5 RNASE3
30 trachea leiomyoma 10.7 CCL11 IL5 RNASE3
31 aortic arch interruption 10.7 IL5 TNF
32 myofascial pain syndrome 10.7 CCL11 CXCL8 IL5
33 female urethral cancer 10.7 CCL11 IL5 RNASE3
34 viljoen kallis voges syndrome 10.7 CCL11 IL5 RNASE3
35 labyrinthine bilateral reactive loss 10.7 ALB CXCL8 ELANE
36 migraine with brainstem aura 10.7 MPO TNF
37 leukocyte disease 10.7 CCL11 IL5 RNASE3
38 endocardium cancer 10.7 CCL11 IL5 RNASE3
39 facial dermatosis 10.7 MPO RNASE3 TNF
40 inflamed seborrheic keratosis 10.7 CCL11 IL5 RNASE3
41 louping ill 10.7 CXCL8 MPO TNF
42 basidiobolomycosis 10.6 CXCL8 TNF
43 signet ring cell adenocarcinoma 10.6 IL5 RNASE3 TNF
44 conjunctival concretion 10.6 CCL11 CXCL8 IL5
45 alcohol abuse 10.6 CXCL8 ELANE TNF
46 adenocarcinoid tumor 10.6 CXCL8 ELANE TNF
47 neonatal period electroclinical syndrome 10.6 CXCL8 ELANE TNF
48 arthus reaction 10.6 ALB MPO TNF
49 churg-strauss syndrome 10.6 CXCL8 IL5 TNF
50 exophthalmos 10.5 CXCL8 ELANE IL5 RNASE3

Comorbidity relations with Bronchitis via Phenotypic Disease Network (PDN): (show top 50) (show all 129)


Acquired Polycythemia Active Peptic Ulcer Disease
Acute Conjunctivitis Acute Cor Pulmonale
Acute Cystitis Acute Ethmoiditis
Acute Frontal Sinusitis Acute Kidney Failure
Acute Maxillary Sinusitis Agammaglobulinemia, X-Linked 1
Allergic Rhinitis Alzheimer Disease
Anthracosis Anxiety Disorder
Asbestosis Aspergillosis
Asthma Susceptibility, Phf11-Related Atrophic Gastritis
Benign Essential Hypertension Bronchiectasis
Bronchopneumonia Cardiac Arrest
Cardiomyopathy, Familial Hypertrophic Cerebral Atherosclerosis
Cerebral Degeneration Cerebrovascular Disease
Chronic Ethmoiditis Chronic Frontal Sinusitis
Chronic Kidney Failure Chronic Laryngitis
Chronic Maxillary Sinusitis Chronic Myocardial Ischemia
Chronic Pulmonary Heart Disease Chronic Rhinitis
Common Cold Conjunctivitis
Cystitis Decubitus Ulcer
Deficiency Anemia Diabetic Polyneuropathy
Diaphragm Disease Duodenitis
Dyskinesia of Esophagus Dysthymic Disorder
Encephalopathy Esophageal Candidiasis
Esophageal Disease Esophagitis
Familial Atrial Fibrillation First-Degree Atrioventricular Block

Graphical network of the top 20 diseases related to Bronchitis:



Diseases related to Bronchitis

Symptoms & Phenotypes for Bronchitis

UMLS symptoms related to Bronchitis:


coughing, fever, pruritus, snoring, recurrent pharyngitis

MGI Mouse Phenotypes related to Bronchitis:

44
id Description MGI Source Accession Score Top Affiliating Genes
1 hematopoietic system MP:0005397 9.7 CCL11 CD40LG CD79A CFTR ELANE IL5
2 immune system MP:0005387 9.36 CFTR ELANE IL5 MPO SERPINB1 SLPI

Drugs & Therapeutics for Bronchitis

FDA approved drugs:

(show all 6)
id Drug Name Active Ingredient(s) 17 Company Approval Date
1
Augmentin 17 AMOXICILLIN; CLAVULANATE POTASSIUM SmithKline Beecham February 1996
2
Avelox I.V. 17 MOXIFLOXACIN HYDROCHLORIDE Bayer November 2001
3
Biaxin XL 17 CLARITHROMYCIN Abbott Laboratories March 2000
4
Cedax 17 CEFTIBUTEN DIHYDRATE Schering-Plough December 1995
5
Ceftin 17 CEFUROXIME AXETIL GlaxoSmithKline September 1997
6
Tequin 17 Bristol-Myers Squibb December, 1999

Drugs for Bronchitis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 337)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Bambuterol Approved Phase 4 81732-65-2, 81732-46-9 54766
2
Terbutaline Approved Phase 4 23031-25-6 5403
3
Budesonide Approved Phase 4,Phase 2 51333-22-3 63006 5281004
4
Montelukast Approved Phase 4,Phase 3,Phase 2 158966-92-8 5281040
5
Bromhexine Approved Phase 4 3572-43-8
6
Epinephrine Approved, Vet_approved Phase 4,Phase 3,Phase 2 51-43-4 5816
7 Racepinephrine Approved Phase 4,Phase 3,Phase 2
8
Dexamethasone Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 50-02-2 5743
9
Levofloxacin Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 100986-85-4 149096
10
Ofloxacin Approved Phase 4,Phase 3,Phase 2,Phase 1 82419-36-1 4583
11
Acetylcysteine Approved, Investigational Phase 4,Phase 2 616-91-1 12035
12
Etanercept Approved, Investigational Phase 4,Phase 1,Phase 2 185243-69-0
13
Amoxicillin Approved, Vet_approved Phase 4,Phase 3 26787-78-0 33613 2171
14
Estradiol Approved, Investigational, Vet_approved Phase 4,Phase 3 50-28-2 5757
15
Ethinyl Estradiol Approved Phase 4,Phase 3 57-63-6 5991
16
Moxifloxacin Approved, Investigational Phase 4,Phase 3 354812-41-2, 151096-09-2 152946
17
Norgestimate Approved Phase 4,Phase 3 35189-28-7 6540478
18
Azithromycin Approved Phase 4,Phase 3,Phase 2,Phase 1 83905-01-5 55185 53477736 447043
19
Telithromycin Approved Phase 4 191114-48-4 5462516
20
Cefuroxime Approved Phase 4,Phase 3 55268-75-2 5361202 5479529
21
Ephedrine Approved Phase 4,Phase 3,Phase 2 299-42-3 9294
22
Guaifenesin Approved, Vet_approved Phase 4,Phase 3 93-14-1 3516
23
Pseudoephedrine Approved Phase 4,Phase 3,Phase 2 90-82-4 7028
24
Clarithromycin Approved Phase 4,Phase 3 81103-11-9 84029
25
Erythromycin Approved, Vet_approved Phase 4 114-07-8 12560
26
Doxycycline Approved, Investigational, Vet_approved Phase 4 564-25-0 54671203
27
Losartan Approved Phase 4 114798-26-4 3961
28
Sulfamethoxazole Approved Phase 4 723-46-6 5329
29
Trimethoprim Approved, Vet_approved Phase 4 738-70-5 5578
30
Zinc Approved Phase 4,Phase 3 7440-66-6 32051 23994
31
Aztreonam Approved Phase 4 78110-38-0 5362041 5742832
32
Mechlorethamine Approved Phase 4,Phase 2,Phase 3 51-75-2 4033
33
Methylprednisolone Approved, Vet_approved Phase 4 83-43-2 6741
34
Prednisolone Approved, Vet_approved Phase 4 50-24-8 5755
35
Prednisone Approved, Vet_approved Phase 4,Phase 2,Phase 3,Phase 1 53-03-2 5865
36
Acetazolamide Approved, Vet_approved Phase 4 59-66-5 1986
37
Cholecalciferol Approved, Nutraceutical Phase 4,Phase 3,Phase 1,Phase 2 67-97-0 6221 10883523 5280795
38
Ergocalciferol Approved, Nutraceutical Phase 4,Phase 3,Phase 1,Phase 2 50-14-6 5280793
39
Vitamin D Approved, Nutraceutical, Vet_approved Phase 4,Phase 3,Phase 1,Phase 2 1406-16-2
40
Folic Acid Approved, Nutraceutical, Vet_approved Phase 4,Phase 1 59-30-3 6037
41
leucovorin Approved, Nutraceutical Phase 4,Phase 1 58-05-9 143 6006
42
Angiotensin II Investigational Phase 4 68521-88-0, 4474-91-3, 11128-99-7 172198 65143
43
BCG vaccine Investigational Phase 4
44 Andrographolide Investigational Phase 4 5508-58-7
45 Adrenergic Agents Phase 4,Phase 3,Phase 2,Phase 1
46 Adrenergic Agonists Phase 4,Phase 3,Phase 2,Phase 1
47 Adrenergic beta-2 Receptor Agonists Phase 4,Phase 3,Phase 2,Phase 1
48 Adrenergic beta-Agonists Phase 4,Phase 3,Phase 2,Phase 1
49 Anti-Asthmatic Agents Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1
50 Autonomic Agents Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1

Interventional clinical trials:

(show top 50) (show all 579)

id Name Status NCT ID Phase Drugs
1 The Effect of Bronchodilator on Eosinophilic Bronchitis and Cough Variant Asthma Unknown status NCT02002754 Phase 4 Bambuterol Hydrochloride tablets
2 Therapeutic Effect of Different Treatment Course With Inhaled Corticosteroids in Eosinophilic Bronchitis Patients Unknown status NCT02002715 Phase 4 Inhaled budesonide
3 Efficacy and Safety of add-on Montelukast to Inhaled Budesonide in the Treatment of Nonasthmatic Eosinophilic Bronchitis Unknown status NCT01121016 Phase 4 Montelukast
4 Airway Clearance for Prevention of COPD Exacerbation Unknown status NCT00181207 Phase 4
5 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effect of Roflumilast on Endothelial Function in Patients With Chronic Obstructive Pulmonary Disease Unknown status NCT01595750 Phase 4 Roflumilast 500;Placebo
6 Effects of Exercise Training on Systemic Inflammation an Muscle Repair According to the Obstructive Chronic Pulmonary Disease (COPD) Phenotype Unknown status NCT01431625 Phase 4
7 Sunovion Brovana Versus Serevent Inspiratory Capacity High Resolution Computed Tomography Unknown status NCT01361984 Phase 4 Nebulized arformoterol;Salmeterol
8 Small Airways Evaluation and Treatment Unknown status NCT02526758 Phase 4 beclomethasone;formoterol;budesonide
9 Optimizing Influenza Vaccination in Surgical Oncology Patients Unknown status NCT01698177 Phase 4
10 Effect of Vitamin D Supplementation in Young South African Children Hospitalized With Acute Lower Respiratory Infection Unknown status NCT02054182 Phase 4 Vitamin D
11 Efficacy and Safety of 3% Hypertonic Saline Inhalation (24h vs 72h) to Treat Acute Bronchiolitis in Hospitalized Infants Unknown status NCT02538458 Phase 4 3 % hypertonic saline up to 72H;3 % hypertonic saline up to 24H
12 Home Oxygen Therapy in Bronchiolitis Unknown status NCT01216553 Phase 4
13 Bronchiolitis All-study, SE-Norway Unknown status NCT00817466 Phase 4 Racemic adrenaline;Isotonic saline
14 Nebulized 3% Hypertonic Saline in the Treatment of Acute Bronchiolitis in the Emergency Department Unknown status NCT01660867 Phase 4 3% saline + oral placebo;0.9% saline + oral dexamethasone
15 Moxifloxacin Versus Amoxicillin Clavulanic Acid in Treatment of Acute Exacerbation of Chronic Bronchitis Completed NCT00656747 Phase 4 Avelox (Moxifloxacin, BAY12-8039);Amoxicillin clavulanic acid
16 Mucolytic Effectiveness of Tacholiquine ® in Chronic Bronchitis Completed NCT02515799 Phase 4 Tacholiquine
17 The Effectiveness of Roflumilast in Improving Mucociliary Clearance in Patients With COPD and Chronic Bronchitis Completed NCT03073798 Phase 4 Roflumilast;Placebo
18 Telithromycin: in the Treatment of Acute Exacerbation of Chronic Bronchitis in Adult Outpatients With COPD Completed NCT00538148 Phase 4 Telithromycin
19 PERSPECTIVE: Telithromycin - Acute Exacerbation of Chronic Bronchitis Completed NCT00132938 Phase 4 telithromycin
20 Study of Azithromycin for Lymphocytic Bronchiolitis/Bronchitis After Lung Transplantation Completed NCT01109160 Phase 4 Azithromycin Dihydrate
21 Ceftidoren Versus Levofloxacin in the Treatment of Patients With Acute Exacerbations of Chronic Bronchitis (AECB) Completed NCT01467297 Phase 4 ceftidoren;levofloxacin
22 Ketek in CAP / AECB in Ambulatory Adult Patients Completed NCT00546676 Phase 4 Telithromycin
23 Efficacy Safety Study of Arformoterol/Tiotropium Combination Versus Either Therapy Alone in Chronic Obstructive Pulmonary Disease (COPD) Completed NCT00424528 Phase 4 Arformoterol Tartrate Inhalation Solution;Tiotropium;Arformoterol and Tiotropium;Placebo
24 Relative Potency of Inhaled Corticosteroids Completed NCT00292838 Phase 4 fluticasone 25, 50, 100, 200 mcg
25 Phase 4 Study - Mucinex D as Adjunct Therapy Completed NCT00441246 Phase 4 Mucinex D (600 mg guaifenesin and 60 mg pseudoephedrine HCl extended-release bi-layer tablets)
26 Chronic Obstructive Pulmonary Disease (COPD) Post-hospitalization Study Completed NCT01110200 Phase 4 ADVAIR DISKUS 250/50 mg BID;SEREVENT 50 mcg BID
27 Add-on Effects of Tiotropium Over Formoterol in Exercise Tolerance on Chronic Obstructive Pulmonary Disease Patients Completed NCT00680056 Phase 4 Formoterol plus Placebo (Tiotropium);Formoterol plus Tiotropium
28 COPD on Primary Care Treatment (COOPT) Completed NCT00184977 Phase 4 N-acetylcysteine;fluticasone propionate
29 Inhaled Steroid Reduces Systemic Inflammation in COPD Completed NCT00175565 Phase 4 inhaled fluticasone 500 mcg b.i.d.
30 Aizthromycin or Clarithromycin in H-pylori Eradication Regimen Completed NCT01667692 Phase 4 azithromycin;clarithmycin
31 Clinical Trial for the Assessment of Delayed Antibiotic Treatment in Pediatric (DAP-Pediatrics) Completed NCT01800747 Phase 4
32 Roflumilast on Markers of Bone Metabolism and Endothelial Function in COPD Completed NCT01745848 Phase 4 Roflumilast
33 Placebo Versus Antibiotics in Acute Exacerbations of Chronic Obstructive Pulmonary Disease (COPD) Completed NCT00170222 Phase 4 doxycycline
34 BENEFITS OF ACLIDINIUM BROMIDE IN THE RELIEF OF COPD SYMPTOMS INCLUDING COUGH Completed NCT02375724 Phase 4 Aclidinium Bromide;Placebo
35 Study of Enbrel in Rheumatoid Arthritis (RA) Subjects With Comorbid Disorders Completed NCT00132418 Phase 4 Enbrel;Placebo
36 Efficacy of Losartan in Preventing Progression of COPD Completed NCT00720226 Phase 4 Losartan;Placebo
37 Change of Inspiratory Peak Flow in COPD Completed NCT00561886 Phase 4 Formoterol
38 Advair HFA For Chronic Obstructive Pulmonary Disease(COPD) Completed NCT00633217 Phase 4 Fluticasone Propionate/Salmeterol DISKUS 250/50mcg;Fluticasone Propionate/Salmeterol Hydrofluoroalkane 134a MDI 230/42mcg
39 Telithromycin in Respiratory Tract Infections Completed NCT00261105 Phase 4 telithromycin
40 Proteomic Profiling for Influenza Completed NCT00133588 Phase 4
41 Roflumilast in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Fixed Combinations of Long-acting β2-agonists (LABA) and Inhaled Glucocorticosteroid (ICS) Completed NCT01329029 Phase 4 Roflumilast;Placebo
42 Effect of Weight and/or Obesity on Sulfamethoxazole and Trimethoprim Concentrations Completed NCT01167452 Phase 4 Sulfamethoxazole/trimethoprim
43 Effectiveness of Different Exercise Training Programs to the Profile of COPD Patients Completed NCT01336283 Phase 4
44 Clinical Trial for the Assessment of Delayed Antibiotic Treatment Strategies Completed NCT01363531 Phase 4
45 Bacille Calmette Guérin Immunisation at Birth and Childhood Morbidity in Danish Children. Completed NCT01694108 Phase 4
46 An Investigation of the Mechanism of Action of Seretide in Chronic Obstructive Pulmonary Disease Completed NCT00974805 Phase 4 Seretide 500 Accuhaler
47 Efficacy of Temporary Positive Expiratory Pressure (TPEP) in Chronic Hypersecretion Completed NCT00700388 Phase 4
48 Efficacy Safety Study of Arformoterol QD Dosing Versus BID Dosing in COPD Completed NCT00571428 Phase 4 Arformoterol Tartrate Inhalation Solution;Arformoterol Tartrate Inhalation Solution;Placebo
49 A 16-Week Study to Evaluate the Effect of Advair DISKUS™ 250/50mcg on Arterial Stiffness in Subjects With Chronic Obstructive Pulmonary Disease (COPD) Completed NCT00857766 Phase 4 ADVAIR DISKUS™ 250/50mcg
50 Study of the Effect of the ROX AC1 on Exercise Capacity and Quality of Life in Chronic Obstructive Pulmonary Disease (COPD) Patients Completed NCT00832611 Phase 4

Search NIH Clinical Center for Bronchitis

Inferred drug relations via UMLS 69 / NDF-RT 48 :


Cochrane evidence based reviews: bronchitis

Genetic Tests for Bronchitis

Genetic tests related to Bronchitis:

id Genetic test Affiliating Genes
1 Chronic Bronchitis 29

Anatomical Context for Bronchitis

MalaCards organs/tissues related to Bronchitis:

39
Lung, Testes, Skin, Heart, Bone, Tonsil, Bone Marrow

Publications for Bronchitis

Articles related to Bronchitis:

(show top 50) (show all 904)
id Title Authors Year
1
Complete genome sequences of two avian infectious bronchitis viruses isolated in Egypt: Evidence for genetic drift and genetic recombination in the circulating viruses. ( 28495648 )
2017
2
Metalworking fluids: a new cause of occupational non-asthmatic eosinophilic bronchitis. ( 28507075 )
2017
3
Epidemiology and impact of chronic bronchitis in chronic obstructive pulmonary disease. ( 28798087 )
2017
4
Aspergillus Bronchitis in Patients with Cystic Fibrosis. ( 28819878 )
2017
5
Genome characterization, antigenicity and pathogenicity of a novel infectious bronchitis virus type isolated from south China. ( 28800976 )
2017
6
A lesson in plasticity: a 74-year-old man with plastic bronchitis. ( 28373346 )
2017
7
Infectious Bronchitis Virus Variants: Molecular Analysis and Pathogenicity Investigation. ( 28937583 )
2017
8
Pathogenicity study of Iranian genotype of avian infectious bronchitis virus (IR-1). ( 28473895 )
2017
9
Eosinophilic Bronchitis. ( 28854083 )
2017
10
Different evolutionary trajectories of vaccine-controlled and non-controlled avian infectious bronchitis viruses in commercial poultry. ( 28472110 )
2017
11
Early investigational antibiotics for the treatment of acute exacerbations of chronic bronchitis. ( 28092467 )
2017
12
Airway Mucin Concentration as a Marker of Chronic Bronchitis. ( 28877023 )
2017
13
A review on antiviral activity of the Himalayan medicinal plants traditionally used to treat bronchitis and related symptoms. ( 27905101 )
2017
14
Vaccination against infectious bronchitis virus: A continuous challenge. ( 28081857 )
2017
15
Use of aerosol inhalation treatment with budesonide and terbutaline sulfate on acute pediatric asthmatic bronchitis. ( 28810628 )
2017
16
Diagnostic accuracy of fractional exhaled nitric oxide in predicting cough variant asthma and eosinophilic bronchitis in adult patients with chronic cough: A systematic review and meta-analysis. ( 28088474 )
2017
17
Strategies to Prevent Cast Formation in Patients with Plastic Bronchitis Undergoing Heart Transplantation. ( 28101662 )
2017
18
Plastic bronchitis: a rare complication of long-term haemodialysis catheter placement in a child. ( 28642998 )
2017
19
Fatal Progressive Membranous Obliterative Bronchitis: A Sequela of Influenza? ( 27984386 )
2017
20
Plastic bronchitis: An unusual complication of acute chest syndrome in adult. ( 28443234 )
2017
21
Eotaxin and IL-4 levels are increased in induced sputum and correlate with sputum eosinophils in patients with nonasthmatic eosinophilic bronchitis. ( 28353595 )
2017
22
Cross-sectional evaluation of the Bronchitis Severity Score in Egyptian children: A move to reduce antibiotics. ( 28395688 )
2017
23
The papain-like protease of avian infectious bronchitis virus has deubiquitinating activity. ( 28316013 )
2017
24
Plastic bronchitis in a patient with silicosis. ( 28365186 )
2017
25
Percutaneous thoracic duct intervention to treat plastic bronchitis related to Fontan palliation. ( 28869334 )
2017
26
The effect of diatomaceous earth in live, attenuated infectious bronchitis vaccine, immune responses, and protection against challenge. ( 28419351 )
2017
27
Network meta-analysis of success rate and safety in antibiotic treatments of bronchitis. ( 28848340 )
2017
28
Protracted bacterial bronchitis in children. ( 28828815 )
2017
29
Successful Thoracic Duct Ligation for Plastic Bronchitis in an Adult. ( 28528062 )
2017
30
Combination of H120 and 1/96 avian infectious bronchitis virus vaccine strains protect chickens against challenge with IS/1494/06 (variant 2)-like infectious bronchitis virus. ( 28523921 )
2017
31
Genetic Characterisation and Analysis of Infectious Bronchitis Virus Isolated from Brazilian flocks between 2010 and 2015. ( 28805451 )
2017
32
First characterization of a Middle-East GI-23 lineage (Var2-like) of infectious bronchitis virus in Europe. ( 28923510 )
2017
33
Recurrence of Protracted Bacterial Bronchitis in Children: What Can We Do? ( 28390630 )
2017
34
Phylogenetic analysis of avian infectious bronchitis virus isolates from Morocco: a retrospective study (1983 to 2014). ( 28421419 )
2017
35
Infectious Bronchitis Virus Infection Induces Apoptosis during Replication in Chicken Macrophage HD11 Cells. ( 28933760 )
2017
36
New real time and conventional RT-PCRs for updated molecular diagnosis of infectious bronchitis virus infection (IBV) in chickens in Egypt associated with frequent co-infections with avian influenza and Newcastle Disease viruses. ( 28336367 )
2017
37
Reverse Genetics System for the Avian Coronavirus Infectious Bronchitis Virus. ( 28508215 )
2017
38
Astragalus polysaccharides enhance the immune response to avian infectious bronchitis virus vaccination in chickens. ( 28826771 )
2017
39
Bronchitis, Acute ( 28846312 )
2017
40
Management and Treatment of Pediatric Plastic Bronchitis. ( 28238517 )
2017
41
Origin and evolution of LX4 genotype infectious bronchitis coronavirus in China. ( 28062013 )
2017
42
Identification and molecular characterization of a novel serotype infectious bronchitis virus (GI-28) in China. ( 28062000 )
2017
43
The Important Role of Lipid Raft-Mediated Attachment in the Infection of Cultured Cells by Coronavirus Infectious Bronchitis Virus Beaudette Strain. ( 28081264 )
2017
44
Erratum: Current asthma contributes as much as smoking to chronic bronchitis in middle age: a prospective population-based study [Corrigendum]. ( 28360518 )
2017
45
Ochroconis gallopava bronchitis mimicking haemoptysis in a patient with bronchiectasis. ( 28884072 )
2017
46
Specific detection of GII-1 lineage of infectious bronchitis virus. ( 28493279 )
2017
47
Network pharmacology-based identification of key pharmacological pathways of Yin-Huang-Qing-Fei capsule acting on chronic bronchitis. ( 28053519 )
2017
48
Protection against infectious bronchitis virus by spike ectodomain subunit vaccine. ( 28899630 )
2017
49
ERS statement on protracted bacterial bronchitis in children. ( 28838975 )
2017
50
Assessment of molecular and genetic evolution, antigenicity and virulence properties during the persistence of the infectious bronchitis virus in broiler breeders. ( 28895517 )
2017

Variations for Bronchitis

Expression for Bronchitis

Search GEO for disease gene expression data for Bronchitis.

Pathways for Bronchitis

Pathways related to Bronchitis according to GeneCards Suite gene sharing:

(show all 13)
id Super pathways Score Top Affiliating Genes
1
Show member pathways
13.78 CCL11 CD40LG CD79A CXCL8 ELANE HSP90AB1
2
Show member pathways
12.44 CCL11 CD40LG CXCL8 HSP90AB1 IL5 RNASE3
3
Show member pathways
12 CCL11 CFTR CXCL8 TNF
4 11.77 CD79A IL5 MPO TNF
5
Show member pathways
11.77 CCL11 CFTR CXCL8 HSP90AB1 IL5 TNF
6 11.55 CD40LG IL5 TNF
7
Show member pathways
11.5 CD40LG CXCL8 IL5 TNF
8 11.49 CCL11 CD40LG IL5
9
Show member pathways
11.47 CD40LG CXCL8 TNF
10 11.32 CD40LG CXCL8 TNF
11 11.29 ELANE MPO TNF
12 10.89 CCL11 CD40LG CXCL8 IL5 TNF
13 10.82 CCL11 CXCL8 IL5 SERPINA1 TNF

GO Terms for Bronchitis

Cellular components related to Bronchitis according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 extracellular space GO:0005615 9.77 ALB CCL11 CD40LG CXCL8 ELANE IL5
2 extracellular region GO:0005576 9.5 ALB CCL11 CD40LG CXCL8 ELANE HSP90AB1
3 azurophil granule lumen GO:0035578 9.33 ELANE MPO RNASE3

Biological processes related to Bronchitis according to GeneCards Suite gene sharing:

(show all 12)
id Name GO ID Score Top Affiliating Genes
1 immune response GO:0006955 9.8 CCL11 CD40LG CXCL8 IL5 SLPI TNF
2 response to lipopolysaccharide GO:0032496 9.73 ELANE MPO SLPI TAC1
3 defense response to bacterium GO:0042742 9.65 ELANE MPO RNASE3 SLPI TNF
4 inflammatory response GO:0006954 9.63 CCL11 CD40LG CXCL8 IL5 TAC1 TNF
5 positive regulation of protein localization to cell surface GO:2000010 9.51 HSP90AB1 TNF
6 positive regulation of podosome assembly GO:0071803 9.49 IL5 TNF
7 response to salt stress GO:0009651 9.48 HSP90AB1 TNF
8 positive regulation of interleukin-8 biosynthetic process GO:0045416 9.46 ELANE TNF
9 response to yeast GO:0001878 9.4 ELANE MPO
10 regulation of immunoglobulin secretion GO:0051023 9.37 CD40LG TNF
11 neutrophil degranulation GO:0043312 9.17 ELANE HSP90AB1 MPO RNASE3 SERPINA1 SERPINB1
12 negative regulation of growth of symbiont in host GO:0044130 9.13 ELANE MPO TNF

Molecular functions related to Bronchitis according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 cytokine activity GO:0005125 9.02 CCL11 CD40LG CXCL8 IL5 TNF

Sources for Bronchitis

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via HPO
66 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....